Beckman Completes Hybritech Purchase

Beckman Instruments has completed its acquisition of San Diego-based Hybritech Inc., a diagnostics company, from Eli Lilly & Co. Terms were not disclosed.

Eli Lilly of Indianapolis said in September it was planning to sell Hybritech as part of Lilly’s plan to separate diagnostic and medical-devices businesses from its pharmaceutical operations. Beckman develops and manufactures automated systems and supplies for laboratories.